University of Minnesota: Communicable Diseases trials
The registry lists 14 Communicable Diseases studies with University of Minnesota as lead sponsor. 1 are open to participants now and 8 have results posted.
Phase 1 3Phase 2 7Phase 3 3Phase 4 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- An International Observational Study of Adults With Acute InfectionRecruitingNCT07069400
- Losartan for Patients With COVID-19 Requiring HospitalizationCompletedNCT04312009Phase 2Results posted
- Losartan for Patients With COVID-19 Not Requiring HospitalizationCompletedNCT04311177Phase 2Results posted
- Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2CompletedNCT04308668Phase 3Results posted
- Cryptococcal Antigen Screening Plus SertralineTerminatedNCT03002012Phase 3Results posted
- S. Aureus Screening and DecolonizationCompletedNCT02182115Phase 4Results posted
- ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney TransplantationCompletedNCT01972035Phase 2Results posted
- Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIVCompletedNCT01852942Phase 2Results posted
- Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus InfectionCompletedNCT00575185Phase 1/2Results posted
- Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in MinnesotaWithdrawnNCT04473183
- N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIVWithdrawnNCT04144335Phase 1/2
- Raltegravir Activity In Lymphoid TissuesWithdrawnNCT00863668Not applicable
- Controlled Trial of Valacyclovir in Infectious MononucleosisCompletedNCT00274404Phase 1/2
- Impact of Sterilization Technique on Incidence of Urinary Tract Infection After CystoscopyCompletedNCT00177112Phase 3